Search Results - "Haahr, Poul‐Martin"

Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes by Marso, Steven P, McGuire, Darren K, Zinman, Bernard, Poulter, Neil R, Emerson, Scott S, Pieber, Thomas R, Pratley, Richard E, Haahr, Poul-Martin, Lange, Martin, Brown-Frandsen, Kirstine, Moses, Alan, Skibsted, Simon, Kvist, Kajsa, Buse, John B

“…In this randomized, double-blind trial involving patients with type 2 diabetes at high risk for cardiovascular events, basal insulin degludec was noninferior…”
Get full text

Prevalence of Baseline Cardiac Arrhythmias in Participants with Overweight or Obesity in Phase 1 Clinical Trials: Analysis of 24‐Hour Holter Electrocardiogram Recordings by Skovgaard, Dorthe, Haahr, Poul‐Martin, Lester, Robert, Clark, Katherine, Paglialunga, Sabina, Finer, Nick, Friedrichsen, Martin H., Hjerpsted, Julie B., Engelmann, Mads D.M.

“…Although estimates of the prevalence of cardiac arrhythmias in healthy volunteers exist, there is a lack of baseline data in other specific populations, such…”
Get full text

Design of DEVOTE (Trial Comparing Cardiovascular Safety of Insulin Degludec vs Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events) – DEVOTE 1 by Marso, Steven P., McGuire, Darren K., Zinman, Bernard, Poulter, Neil R., Emerson, Scott S., Pieber, Thomas R., Pratley, Richard E., Haahr, Poul-Martin, Lange, Martin, Frandsen, Kirstine Brown, Rabøl, Rasmus, Buse, John B.

“…DEVOTE was designed to evaluate the cardiovascular safety of insulin degludec (IDeg) vs insulin glargine U100 (IGlar) in patients with T2D at high risk of…”
Get full text

In vitro immunomodulatory effects of pentoxifylline by Rieneck, K, Diamant, M, Haahr, P M, Schönharting, M, Bendtzen, K

“…Pentoxifylline (PTX), a methylxanthine derivative and phosphodiesterase inhibitor, is known to influence production and/or function of some cytokines. We…”
Get more information

Plasma concentration of hGH and anti-hGH antibodies after subcutaneous administration of hGH for 3 weeks to immunosuppressed pigs by Agersø, Henrik, Wilken, Michael, Drustrup, Jørn, Haahr, Poul-Martin, Jørgensen, Karin Damm

“…Objective: The objective of the present study was to evaluate the dosing regimen of immunosuppressants necessary to avoid the formation of anti-hGH antibodies…”
Get full text

Cardiovascular safety of insulin degludec versus insulin glargine in patients at high risk of cardiovascular events: Design of the DEVOTE Cardiovascular Outcomes Trial (DEVOTE 1) by Marso, Steven P., MD, McGuire, Darren K., MD, MHSc, Zinman, Bernard, MD, FRCPC, FACP, Poulter, Neil R., FMedSci, Emerson, Scott S., MD, PhD, Pieber, Thomas R., MD, Pratley, Richard E., MD, Haahr, Poul-Martin, MD, Lange, Martin, MD, PhD, Frandsen, Kirstine Brown, MD, Rabøl, Rasmus, MD, PhD, Buse, John B., MD, PhD

“…Abstract The Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular…”
Get full text